Cancer treatment makes Endocyte premium takeover target
Now that Indiana-based Endocyte Inc.’s experimental cancer treatment is proving successful, the company may command a takeover bid at one of the industry’s highest premiums on record.
Bloomberg News
Articles
Would-be Lilly competitor’s inhaled insulin tied to lung concerns
Afrezza, a powdered insulin used through an inhaler, would be the MannKind Corp.’s first marketed product. The treatment would compete against Lilly’s Humalog. An FDA report tied the drug to a decline in lung function.
Football labor decision might hurt schools, Moody’s says
Lawsuits challenging amateurism in U.S. college sports may result in higher costs for universities and the National Collegiate Athletic Association, Moody’s Investors Service said Thursday.
Northwestern football ruling seen changing college sports
In a stunning ruling that could revolutionize a college sports industry worth billions of dollars and have dramatic repercussions for the Indianapolis-based NCAA, a federal agency said Wednesday that players at Northwestern can unionize.
Simon says court should dismiss CEO pay case
Simon Property Group told a Delaware judge on Tuesday that an investor lawsuit over David Simon’s huge pay package should be thrown out now that the company has rewritten the compensation plan.
WellPoint sees double-digit rate rise for Obamacare in 2015
Two months before health insurers must submit rate proposals for 2015 to government regulators, WellPoint Inc. fired a surprising shot across their bow.
U.S. steelmakers accuse South Korea of dumping
U.S. Steel and Steel Dynamics Inc., which have thousands of employees in Indiana, are among steel companies who say they have been unfairly harmed as imports of the products are sold more cheaply than domestic producers can make them.
Undertaker mayor says Connersville will cheat death
The mayor of Connersville declared a financial emergency three months into budget year.The culprit is the loss of a single employer, Visteon Corp., which closed an auto-parts plant in 2008, throwing 900 people out of work.
Endocyte stock doubles after key approval in Europe
The stock price of Endocyte Inc. skyrocketed by as much as 130 percent Friday morning after the drug company got a thumbs up in Europe to market its first drug and received a new round of favorable clinical trial results.
Lilly diabetes drug wins backing from EU regulator
Indianapolis-based Lilly is expected to garner $518 million in annual sales from Jardiance by 2019, according to the average of five analyst estimates compiled by Bloomberg.
Indiana among states probing Comcast-Time Warner deal
Comcast Corp.’s proposed $45 billion acquisition of Time Warner Cable Inc. is being probed by at least six states that have joined a federal review of whether the deal violates antitrust laws.
Discovery may be key to Alzheimer’s treatment
Scientists have discovered that a gene-regulating protein that protects the developing brain of a fetus resurfaces in old age and may stave off dementia, a finding that could open a new path in Alzheimer’s research.
Obamacare shuffles market share in some states, report finds
A snapshot of Obamacare enrollment in seven states suggests the law hasn’t significantly increased competition, but it has shuffled market share for some insurers, including Indianapolis-based WellPoint Inc.
NCAA called ‘cartel’ with top conferences in player suit
The NCAA and five top conferences generate billions of dollars in revenue and illegally cap the pay of student athletes, a group of football and basketball players claim in a new lawsuit that seeks to reshape college sports.
Feds revise for-profit college rules after court block
ITT Educational stock fell Friday after the Obama administration said it has revised its regulatory package for for-profit colleges, rewriting a proposal that the education industry blocked in court almost two years ago.
WellPoint getting unexpected competition from co-ops
Obamacare opponents predicted early on that insurance co-ops created by the law would fail, but several are doing well by combining low premiums with a certain homespun appeal.
Biomet files to sell shares in IPO to pay down debt
Indiana-based Biomet Group Inc., a closely held maker of orthopedic medical devices, had been publicly traded until 2007 when it was acquired by the group of private equity firms.
Office retailer Staples plans to shut down 225 stores
Staples Inc., the largest U.S. office-supplies retail chain, will close as many as 12 percent of its North American stores and cut as much as $500 million in costs as online competition continues to hurt sales.
U.S. job gains exceed predictions, but unemployment rate rises
Employers added more workers than projected in February, while unemployment rose to 6.7 percent from 6.6 percent as more people entered the labor force.
Former college running back sues NCAA over scholarship caps
The Indianapolis-based National Collegiate Athletic Association and five of college football’s regional conferences, including the Big Ten, were sued by a former West Virginia University player who claims they agreed to limit the value of scholarships to less than the actual cost of attendance.